A new drug that could help reduce damage to the body after a heart attack, stroke or major surgery has been developed by UK scientists.
Tests in mice suggest the compound protects the heart when blood flow is restored suddenly after a period when tissue has been starved of oxygen. MitoSNO has yet to be tested on humans, but could lead to a whole new class of medicines.
The research is published in the journal Nature Medicine.
One of the problems after a heart attack is the damage caused to heart tissue when blood flow is restored suddenly after a prolonged period without oxygen. Blood flowing back into the tissues triggers production of harmful molecules, called free radicals, which are generated inside mitochondria - the powerhouses of the cell.
The Food and Drug Administration Monday unveiled the details of a new policy designed to make...
As marijuana use among teens has grown in the past decade, researchers have been trying to...
NYU Langone Health, one of New York City’s major hospital networks, announced this week that it...
